These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7746698)

  • 1. Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children.
    Palusci VJ; O'Hare D; Lawrence RM
    Pediatr Infect Dis J; 1995 Feb; 14(2):144-8. PubMed ID: 7746698
    [No Abstract]   [Full Text] [Related]  

  • 2. Latent tuberculosis in childhood: tolerability of two different therapeutic approaches.
    Tersigni C; Venturini E; Cordola C; Piccini P; Bianchi L; Montagnani C; Sollai S; Chiappini E; de Martino M; Galli L
    Expert Rev Anti Infect Ther; 2018 Apr; 16(4):359-365. PubMed ID: 29465259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver enzyme disturbances during isoniazid chemoprophylaxis in children.
    Beaudry PH; Brickman HF; Wise MB; MacDougall D
    Am Rev Respir Dis; 1974 Nov; 110(5):581-4. PubMed ID: 4429254
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Isoniazid and the liver.
    Hanson AS
    Am Rev Respir Dis; 1974 Dec; 110(6):817. PubMed ID: 4429278
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid hepatotoxicity and acetylation during tuberculosis chemoprophylaxis.
    Myles RK
    Am Rev Respir Dis; 1980 Sep; 122(3):505-6. PubMed ID: 6106445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis.
    Nakajo MM; Rao M; Steiner P
    Pediatr Infect Dis J; 1989 Sep; 8(9):649-50. PubMed ID: 2640548
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoniazid hepatotoxicity in children.
    Rapp RS; Campbell RW; Howell JC; Kendig EL
    Am Rev Respir Dis; 1978 Oct; 118(4):794-6. PubMed ID: 309296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
    Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB
    Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients.
    Thomas PA; Mozes MF; Jonasson O
    Arch Surg; 1979 May; 114(5):597-9. PubMed ID: 375876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
    Linna O; Uhari M
    Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.
    Ben Fredj N; Gam R; Kerkni E; Chaabane A; Chadly Z; Boughattas N; Aouam K
    Pharmacogenomics J; 2017 Jul; 17(4):372-377. PubMed ID: 27089936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of a isoniozid-rifompicin drug hepatotoxicity screening technic in tuberculosis therapy].
    Viteau JM; Toulet J; Plonteux G; Abiven M; Bonfante N
    Sem Hop; 1974 Jun; 50(28):1953-9. PubMed ID: 4374748
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis--new thoughts on an old disease.
    Buechner HA
    J Miss State Med Assoc; 1974 Oct; 15(10):435-8. PubMed ID: 4429623
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children.
    Martinez-Roíg A; Camí J; Llorens-Terol J; de la Torre R; Perich F
    Pediatrics; 1986 Jun; 77(6):912-5. PubMed ID: 3487069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitubercular chemoprevention: hepatotoxicity and therapeutic compliance].
    Hortoneda Giménez M; Alfonso Sánchez JL; Cortés Vizcaíno C; Sabater Pons A
    An Med Interna; 1993 Dec; 10(12):587-9. PubMed ID: 8049323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
    Dieu MJ
    J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Isoniazid and the liver.
    Greenberg HB
    Am Rev Respir Dis; 1975 May; 111(5):708-9. PubMed ID: 1130761
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
    van Hest R; Baars H; Kik S; van Gerven P; Trompenaars MC; Kalisvaart N; Keizer S; Borgdorff M; Mensen M; Cobelens F
    Clin Infect Dis; 2004 Aug; 39(4):488-96. PubMed ID: 15356811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.